Shwachman-Bodian-Diamond syndrome (SBDS) protein is a direct inhibitor of protein phosphatase 2A (PP2A) activity and overexpressed in acute myeloid leukaemia

Affiliations

• ¹ School of Biomedical Sciences and Pharmacy, Faculty of Health and Medicine, University of Newcastle, Callaghan, NSW, Australia. matt.dun@newcastle.edu.au.
• ² Hunter Medical Research Institute, Cancer Research Program, New Lambton Heights, NSW, Australia. matt.dun@newcastle.edu.au.
• ³ School of Biomedical Sciences and Pharmacy, Faculty of Health and Medicine, University of Newcastle, Callaghan, NSW, Australia.
• ⁴ Hunter Medical Research Institute, Cancer Research Program, New Lambton Heights, NSW, Australia.
• ⁵ School of Chemistry, University of New South Wales, Sydney, NSW, Australia.
• ⁶ Centre for Health Technologies and the School of Biomedical Engineering, University of Technology Sydney, Sydney, Australia.
• ⁷ Lowy Cancer Research Centre and the Prince of Wales Clinical School, University of New South Wales, Sydney, Australia.
• ⁸ Children's Cancer Institute Australia, University of New South Wales, Sydney, NSW, Australia.
• ⁹ Calvary Mater Hospital, Newcastle, NSW, Australia.
• ¹⁰ Reproductive Science Group, Faculty of Science, University of Newcastle, Callaghan, NSW, Australia.
• ¹¹ School of Life Sciences, Faculty of Science, University of Technology Sydney, Ultimo, Australia.
• ¹² John Hunter Children's Hospital, New Lambton Heights, NSW, Australia.
• ¹³ NSW Health Pathology, John Hunter Hospital, Lookout Road, New Lambton Heights, NSW, Australia.
• ¹⁴ School of Medicine and Public Health, Faculty of Health and Medicine, University of Newcastle, Callaghan, NSW, Australia.
• ¹⁵ School of Biomedical Sciences and Pharmacy, Faculty of Health and Medicine, University of Newcastle, Callaghan, NSW, Australia. nikki.verrills@newcastle.edu.au.
• ¹⁶ Hunter Medical Research Institute, Cancer Research Program, New Lambton Heights, NSW, Australia. nikki.verrills@newcastle.edu.au.